JANICE NYAMONGO: Open Payments
NPI 1669155123 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 29 payments from 14 companies in 2025. Trend: 2023 $64 · 2024 $909 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| Viatris Specialty LLC | 4 | $111 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $73 |
| Lilly USA, LLC | 4 | $65 |
| Phathom Pharmaceuticals, Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| Novo Nordisk Inc | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| UCB, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $24 |
Products named: YUPELRI, Kerendia, REXULTI, JARDIANCE, MOUNJARO, VOQUEZNA, FARXIGA, Nayzilam.
Industry payments across TX — which companies pay providers there.
